Theraflu 1000 mg/12,2 mg/200 mg pulveris iekšķīgi lietojama šķīduma pagatavošanai 라트비아 - 라트비아어 - Zāļu valsts aģentūra

theraflu 1000 mg/12,2 mg/200 mg pulveris iekšķīgi lietojama šķīduma pagatavošanai

glaxosmithkline dungarvan ltd., ireland - paracetamolum, phenylephrini hydrochloridum, guaifenesinum - pulveris iekšķīgi lietojama šķīduma pagatavošanai - 1000 mg/12,2 mg/200 mg

Femoston conti 0,5 mg/2,5 mg apvalkotās tabletes 라트비아 - 라트비아어 - Zāļu valsts aģentūra

femoston conti 0,5 mg/2,5 mg apvalkotās tabletes

viatris healthcare limited, ireland - estradiolum, dydrogesteronum - apvalkotā tablete - 0,5 mg/2,5 mg

Kanilad 150 mg apvalkotās tabletes 라트비아 - 라트비아어 - Zāļu valsts aģentūra

kanilad 150 mg apvalkotās tabletes

medochemie ltd., cyprus - lakozamīds - apvalkotā tablete - 150 mg

Lacosamide UCB 유럽 연합 - 라트비아어 - EMA (European Medicines Agency)

lacosamide ucb

ucb pharma s.a. - lacosamide - epilepsijas, daļēji - antiepileptics, - lacosamide ucb ir norādīts kā monotherapy un adjunctive terapiju daļēju sākums lēkmju ar vai bez sekundāras vispārināšanas pieaugušajiem, pusaudžiem un bērniem no 4 gadu vecuma ar epilepsiju.

Wipar 500 mg/60 mg + 500 mg/25 mg apvalkotās tabletes 라트비아 - 라트비아어 - Zāļu valsts aģentūra

wipar 500 mg/60 mg + 500 mg/25 mg apvalkotās tabletes

wick pharma, germany - paracetamolum, pseudoephedrini hydrochloridum, diphenhydramini hydrochloridum - apvalkotā tablete - 500 mg/60 mg + 500 mg/25 mg

Perlinring 120/15 mikrogrami/24 stundās vaginālās ievadīšanas sistēma 라트비아 - 라트비아어 - Zāļu valsts aģentūra

perlinring 120/15 mikrogrami/24 stundās vaginālās ievadīšanas sistēma

actavis group ptc ehf., iceland - etonogestrelum, ethinylestradiolum - vaginālās ievadīšanas sistēma - 120/15 mikrogrami/24 stundās

Klimedix 1 mg/2 mg apvalkotās tabletes 라트비아 - 라트비아어 - Zāļu valsts aģentūra

klimedix 1 mg/2 mg apvalkotās tabletes

gedeon richter plc., hungary - estradiolum, drospirenonum - apvalkotā tablete - 1 mg/2 mg

Lacosamide Fresenius Kabi 10 mg/ml šķīdums infūzijām 라트비아 - 라트비아어 - Zāļu valsts aģentūra

lacosamide fresenius kabi 10 mg/ml šķīdums infūzijām

fresenius kabi polska sp.z o.o., poland - lakozamīds - Šķīdums infūzijām - 10 mg/ml

Tibsovo 유럽 연합 - 라트비아어 - EMA (European Medicines Agency)

tibsovo

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiski līdzekļi - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

Lacosamide Adroiq 유럽 연합 - 라트비아어 - EMA (European Medicines Agency)

lacosamide adroiq

extrovis eu ltd. - lacosamide - epilepsija - antiepileptics, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.